Cover Image
市场调查报告书

生物可吸收支架的全球市场预测 2022年:各材质 (高分子支架、金属支架)、吸收速度、用途、终端用户的预测

Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022

出版商 MarketsandMarkets 商品编码 360894
出版日期 内容信息 英文 140 Pages
订单完成后即时交付
价格
Back to Top
生物可吸收支架的全球市场预测 2022年:各材质 (高分子支架、金属支架)、吸收速度、用途、终端用户的预测 Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022
出版日期: 2017年08月21日 内容信息: 英文 140 Pages
简介

全球生物可吸收支架市场规模,预计从2016年的2亿2,360万美元到2022年达4亿1,720万美元,以11.5%的年复合成长率扩大。主要的促进成长要素,是企业对生物可吸收支架临床实验兴趣提高,老年人口的增加,技术进步,及患者对微创治疗的希望。可是,替代品的存在可能某种程度妨碍该市场成长。

本报告提供全球生物可吸收支架市场相关调查,各材质、吸收速度、用途、终端用户,及各地区的市场规模的变化与预测,市场成长的各种影响因素及市场机会分析,竞争环境与市场占有率,以及主要企业的简介等汇整。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 重要考察

  • 市场概要
  • 生物可吸收支架市场:各终端用户
  • 生物可吸收支架市场:各用途
  • 生物可吸收支架市场:各材质
  • 生物可吸收支架市场:各地区

第5章 市场概要

  • 简介
  • 市场动态
    • 促进要素
    • 阻碍要素
    • 机会
    • 课题

第6章 法规情形

  • 简介
  • FDA及CE标志的认证
  • PMA认证及政府认证

第7章 生物可吸收支架市场:各材质

  • 简介
  • 高分子支架
  • 金属支架

第8章 生物可吸收支架市场:各吸收速度

  • 简介
  • 快慢性支架
  • 迅速性支架

第9章 生物可吸收支架市场:各用途

  • 简介
  • 冠状动脉疾病
  • 周边动脉疾病

第10章 生物可吸收支架市场:各终端用户

  • 简介
  • 医院
  • 心脏病中心

第11章 生物可吸收支架市场:各地区

  • 简介
  • 欧洲
  • 亚洲
  • 北美
  • 其他

第12章 竞争环境

  • 简介
  • 市场排行榜分析
  • 竞争的龙头制图
    • 有远见的领导者
    • 创新者
    • 新兴企业
    • 动态区分者
  • 竞争的基准
    • 产品系列的优势
    • 产业策略的优势

第13章 企业简介 (企业概要、服务的优势、产业策略的优势、主要关系处等)

  • ABBOTT
  • REVA MEDICAL, INC.
  • ELIXIR MEDICAL CORPORATION
  • 京都医疗设计
  • BIOTRONIK
  • AMARANTH MEDICAL, INC.
  • ARTERIAL REMODELING TECHNOLOGIES
  • MERIL LIFE SCIENCES PVT. LTD.
  • ARTERIUS LIMITED
  • LEPU MEDICAL TECHNOLOGY CO., LTD.
  • BOSTON SCIENTIFIC CORPORATION
  • 480 BIOMEDICAL
  • S3V VASCULAR TECHNOLOGIES PRIVATE LIMITED
  • QUALIMED (PART OF Q3 MEDICAL GROUP)
  • ORBUSNEICH

第14章 附录

图表

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: MD 4383

"Bioresorbable stents market projected to grow at a CAGR of 11.5% from 2017 to 2022"

The global bioresorbable stents market is expected to reach USD 417.2 million by 2022 from USD 223.6 million in 2016, at a CAGR of 11.5% during the forecast period. Growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients' preference for minimally invasive therapies are factors that are expected to drive the market growth in future. However, the presence of substitutes may restrain the market growth for bioresorbable stents to some extent.

"The coronary artery diseases segment is expected to grow at the highest CAGR during the forecast period"

Based on application, the market is segmented into coronary artery diseases and peripheral artery diseases. In 2017, coronary artery diseases are expected to grow at the highest CAGR during the forecast period. This positive growth is attributed to factors such as rising aging population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.

"Hospitals to dominate the global bioresorbable stents market in 2017"

Based on end users, the market is segmented into hospitals and cardiac centers. The hospitals segment is expected to dominate the market. The dominance of this segment is attributed to the increasing need of surgeries, growing risk of CAD and PAD, and improved reimbursement scenario for hospitals.

"North America to witness high growth during the forecast period"

In 2017, Europe is expected to account for the largest share of the global bioresorbable stents market. The dominance of European region is attributed to factors like increasing regulatory approvals for stents which will facilitate their commercialization and rising research activities for development of bioresorbable stents. Also, North America is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the increasing prevalence of CAD and PAD, patient preference for minimally invasive therapies, unhealthy lifestyle habits, and huge patient pool are enabling this market to grow in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 30%; Tier 2 - 45%; Tier 3 - 25%.
  • By Designation (Supply Side): C-level- 25%; D-level- 30%; Others- 45%.
  • By Region: North America-45%; Europe-35%; Asia-12%; RoW-8%.

List of companies profiled in the report:

  • Abbott
  • REVA Medical, Inc.
  • Elixir Medical Corporation
  • KYOTO MEDICAL PLANNING Co., Ltd.
  • BIOTRONIK
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies
  • Meril Life Sciences
  • Arterius Limited
  • Lepu Medical Technology Co., Ltd.
  • Boston Scientific Corporation
  • 480 Biomedical
  • S3V Vascular Technologies
  • QualiMed
  • ORBUSNEICH

Research Coverage:

The report provides an overview of the global bioresorbable stents market. It aims at estimating the market size and future growth potential of this market across different segments such as material, absorption rate, application, end users, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of the revenue numbers for the overall global bioresorbable stents market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses better and focus on suitable go-to-market strategies. The report also will help the stakeholders understand the pulse of the market and provide them with information regarding key market drivers, restraints challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. SECONDARY DATA
  • 2.3. PRIMARY DATA
  • 2.4. KEY INDUSTRY INSIGHTS
  • 2.5. MARKET SIZE ESTIMATION
  • 2.6. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.7. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIORESORBABLE STENTS MARKET OVERVIEW
  • 4.2. BIORESORBABLE STENTS MARKET, BY END USER
  • 4.3. BIORESORBABLE STENTS MARKET, BY APPLICATION
  • 4.4. BIORESORBABLE STENTS MARKET, BY MATERIAL
  • 4.5. BIORESORBABLE STENTS MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rapidly growing geriatric population and increased risk of CAD and PAD in the elderly
      • 5.2.1.2. Strong product pipeline
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Presence of substitutes
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets to offer high-growth opportunities for market participants
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Product withdrawals and failures
      • 5.2.4.2. High risk of complications

6. REGULATORY SCENARIO

  • 6.1. INTRODUCTION
  • 6.2. FDA AND CE APPROVALS
  • 6.3. PMA APPROVALS AND GOVERNMENT CERTIFICATES

7. BIORESORBABLE STENTS MARKET, BY MATERIAL

  • 7.1. INTRODUCTION
  • 7.2. BIORESORBABLE POLYMER-BASED STENTS
  • 7.3. BIORESORBABLE METALLIC STENTS

8. BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE

  • 8.1. INTRODUCTION
  • 8.2. SLOW-ABSORPTION STENTS
  • 8.3. FAST-ABSORPTION STENTS

9. BIORESORBABLE STENTS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. CORONARY ARTERY DISEASE
  • 9.3. PERIPHERAL ARTERY DISEASE

10. BIORESORBABLE STENTS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. HOSPITALS
  • 10.3. CARDIAC CENTERS

11. BIORESORBABLE STENTS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. EUROPE
    • 11.2.1. GERMANY
    • 11.2.2. FRANCE
    • 11.2.3. U.K.
    • 11.2.4. REST OF EUROPE (ROE)
  • 11.3. ASIA
  • 11.4. NORTH AMERICA
    • 11.4.1. U.S.
    • 11.4.2. CANADA
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. MARKET RANKING ANALYSIS
  • 12.3. COMPETITIVE LEADERSHIP MAPPING
    • 12.3.1. VISIONARY LEADERS
    • 12.3.2. INNOVATORS
    • 12.3.3. EMERGING COMPANIES
    • 12.3.4. DYNAMIC DIFFERENTIATORS
  • 12.4. COMPETITIVE BENCHMARKING
    • 12.4.1. STRENGTH OF THE PRODUCT PORTFOLIO
    • 12.4.2. BUSINESS STRATEGY EXCELLENCE

Abbott, REVA Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd., BIOTRONIK, Amaranth Medical, Inc., Arterial Remodeling Technologies, Meril Life Sciences Pvt. Ltd., Arterius Limited, LEPU MEDICAL TECHNOLOGY CO., LTD., Boston Scientific Corporation, HangZhou HuaAn Biotechnology Co.,Ltd, S3V Vascular Technologies, QualiMed, SMT, TEPHA INC, Manli Cardiology Ltd., ORBUSNEICH, 480. Biomedical, zorion medical inc, Lifetech Scientific (Shenzhen) Co., Ltd.

13. COMPANY PROFILES (Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships)*

  • 13.1. ABBOTT
  • 13.2. REVA MEDICAL, INC.
  • 13.3. ELIXIR MEDICAL CORPORATION
  • 13.4. KYOTO MEDICAL PLANNING CO., LTD.
  • 13.5. BIOTRONIK
  • 13.6. AMARANTH MEDICAL, INC.
  • 13.7. ARTERIAL REMODELING TECHNOLOGIES
  • 13.8. MERIL LIFE SCIENCES PVT. LTD.
  • 13.9. ARTERIUS LIMITED
  • 13.10. LEPU MEDICAL TECHNOLOGY CO., LTD.
  • 13.11. BOSTON SCIENTIFIC CORPORATION
  • 13.12. 480 BIOMEDICAL
  • 13.13. S3V VASCULAR TECHNOLOGIES PRIVATE LIMITED
  • 13.14. QUALIMED (PART OF Q3 MEDICAL GROUP)
  • 13.15. ORBUSNEICH

*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key relationships might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5. AVAILABLE CUSTOMIZATIONS
  • 14.6. RELATED REPORTS
  • 14.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PIPELINE PRODUCTS IN THE BIORESORBABLE STENTS MARKET
  • TABLE 2: LIST OF THE APPROVED PRODUCTS
  • TABLE 3: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 4: BIORESORBABLE POLYMER-BASED STENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: NORTH AMERICA: BIORESORBABLE POLYMER-BASED STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 6: EUROPE: BIORESORBABLE POLYMER-BASED STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: BIORESORBABLE METALLIC STENTS MARKET, BY REGION, 2017-2022 (USD MILLION)
  • TABLE 8: EUROPE: BIORESORBABLE METALLIC STENTS MARKET, BY COUNTRY, 2017-2022 (USD MILLION)
  • TABLE 9: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 10: SLOW-ABSORPTION STENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: EUROPE: SLOW-ABSORPTION STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: NORTH AMERICA: SLOW-ABSORPTION STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: FAST-ABSORPTION STENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: EUROPE: FAST-ABSORPTION STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: FAST-ABSORPTION STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 17: BIORESORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NORTH AMERICA: BIORESORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: EUROPE: BIORESORBABLE STENTS MARKET FOR CORONARY ARTERY DISEASE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: BIORESORBABLE STENTS MARKET FOR PERIPHERAL ARTERY DISEASE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: EUROPE: BIORESORBABLE STENTS MARKET FOR PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 22: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 23: BIORESORBABLE STENTS MARKET FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: BIORESORBABLE STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: EUROPE: BIORESORBABLE STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: BIORESORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: BIORESORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: EUROPE: BIORESORBABLE STENTS MARKET FOR CARDIAC CENTERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: BIORESORBABLE STENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: BIORESORBABLE STENTS MARKET, BY REGION, 2015-2022 (UNITS)
  • TABLE 31: EUROPE: BIORESORBABLE STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: EUROPE: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 33: EUROPE: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 34: EUROPE: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: EUROPE: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 36: GERMANY: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 37: GERMANY: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 38: GERMANY: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: GERMANY: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 40: FRANCE: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 41: FRANCE: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 42: FRANCE: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 43: FRANCE: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 44: U.K.: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 45: U.K.: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 46: U.K.: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: U.K.: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 48: ROE: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 49: ROE: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 50: ROE: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 51: ROE: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: ASIA: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 53: ASIA: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 54: ASIA: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: BIORESORBABLE STENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 57: NORTH AMERICA: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 58: NORTH AMERICA: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 59: NORTH AMERICA: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: NORTH AMERICA: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: U.S.: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 62: U.S.: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 63: U.S.: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: U.S.: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 65: CANADA: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 66: CANADA: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: BIORESORBABLE STENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 69: ROW: BIORESORBABLE STENTS MARKET, BY MATERIAL, 2015-2022 (USD MILLION)
  • TABLE 70: ROW: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE, 2015-2022 (USD MILLION)
  • TABLE 71: ROW: BIORESORBABLE STENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 72: ROW: BIORESORBABLE STENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 73: BIORESORBABLE STENTS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2016

LIST OF FIGURES

  • FIGURE 1: BIORESORBABLE STENTS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 4: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5: MARKET SIZE ESTIMATION: BOTTOM -UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 7: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: BIORESORBABLE POLYMER-BASED STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: BIORESORBABLE STENTS MARKET, BY ABSORPTION RATE (2017 VS 2022)
  • FIGURE 11: CORONARY ARTERY DISEASE TO REGISTER HIGHEST GROWTH IN THE BIORESORBABLE STENTS APPLICATION MARKET (2017-2022)
  • FIGURE 12: HOSPITALS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 13: NORTH AMERICA IS EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: RISING GERIATRIC POPULATION AND INCREASED RISK OF CAD AND PAD TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: HOSPITALS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 16: CORONARY ARTERY DISEASES TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: BIORESORBABLE POLYMER-BASED STENTS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE BIORESORBABLE STENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: BIORESORBABLE STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: PREVALENCE OF CAD, BY AGE AND GENDER (2009-2012)
  • FIGURE 21: BIOABSORBABLE STENTS MARKET, BY MATERIAL (2017 VS 2022)
  • FIGURE 22: SLOW ABSORPTION STENTS TO DOMINATE THE BIORESORBABLE STENTS MARKET IN 2017
  • FIGURE 23: CORONARY ARTERY DISEASE TO DOMINATE THE BIORESORBABLE STENTS APPLICATION MARKET IN 2017
  • FIGURE 24: HOSPITALS TO REGISTER HIGHEST GROWTH IN THE BIORESORBABLE STENTS END-USER MARKET IN 2017
  • FIGURE 25: EUROPE TO DOMINATE THE BIORESORBABLE STENTS MARKET IN 2017
  • FIGURE 26: EUROPE: BIORESORBABLE STENTS MARKET SNAPSHOT
  • FIGURE 27: ASIA: BIORESORBABLE STENTS MARKET SNAPSHOT
  • FIGURE 28: NORTH AMERICA: BIORESORBABLE STENTS MARKET SNAPSHOT
  • FIGURE 29: ROW BIORESORBABLE STENTS MARKET SNAPSHOT (2017)
  • FIGURE 30: COMPETITIVE LEADERSHIP MAPPING
  • FIGURE 31: ABBOTT: COMPANY SNAPSHOT (2016)
  • FIGURE 32: REVA MEDICAL, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 33: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016)
Back to Top